Thomas E. Hogan - 18 Mar 2026 Form 3 Insider Report for Cellebrite DI Ltd. (CLBT)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
3
Accepted by SEC
18 Mar 2026, 08:26:08 UTC
Next SEC filing
07 Jul 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Thomas E. Hogan

Key filing fact

Thomas E. Hogan filed Form 3 for Cellebrite DI Ltd. (CLBT) on 18 Mar 2026.

Key facts

  • This page summarizes Thomas E. Hogan's Form 3 filing for Cellebrite DI Ltd. (CLBT).
  • 0 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 18 Mar 2026, 08:26.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (1)

CIK 0002013619 Primary reporting owner

Hogan Thomas E.

Relationship
Chief Executive Officer, Director
Address
94 SHLOMO SHMELZER ROAD, PETAH TIKVA, ISRAEL
Signature
/s/ Thomas E. Hogan
Signature date
18 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CLBT holding

Ordinary shares, par value NIS 0.00001 ("Ordinary Shares")

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
693,965
Date
18 Mar 2026
Ownership
Direct
Footnotes
F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CLBT holding Derivative

Stock options

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
18 Mar 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
1,000,000
Exercise price
$7.39
Footnotes
F3
CLBT holding Derivative

Stock options

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
18 Mar 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
500,000
Exercise price
$7.39
Footnotes
F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Includes 282,905 Ordinary Shares that are represented by restricted share units ("RSUs") that were granted on September 19, 2025 and vest on July 1, 2026. Each RSU represents a contingent right to receive one Ordinary Share of the Issuer upon settlement.

Footnote F2

Includes 252,748 Ordinary Shares that are represented by RSUs that were granted on February 10, 2026 and vest as follows: 63,196 vest on the one year anniversary of the grant date and 15,796 vest every three months thereafter through February 10, 2030.

Footnote F3

Of these stock options, 625,000 are fully vested and exercisable and 62,500 vest on each of May 7, 2026 and every three months thereafter through August 7, 2027.

Footnote F4

These stock options are fully vested and exercisable.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .